0001209191-20-064062.txt : 20201217
0001209191-20-064062.hdr.sgml : 20201217
20201217163212
ACCESSION NUMBER: 0001209191-20-064062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quimi Daphne
CENTRAL INDEX KEY: 0001543031
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 201396480
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-15
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001543031
Quimi Daphne
C/O AMICUS THERAPEUTICS
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
Chief Financial Officer
Common Stock
2020-12-15
4
M
0
11500
2.94
A
229679
D
Common Stock
2020-12-15
4
M
0
7550
4.38
A
237229
D
Common Stock
2020-12-15
4
M
0
4379
3.53
A
241608
D
Common Stock
2020-12-15
4
M
0
6892
2.45
A
248500
D
Common Stock
2020-12-15
4
F
0
4156
23.86
D
244344
D
Stock Options (right to buy)
2.94
2020-12-15
4
M
0
11500
0.00
D
2024-06-26
Common Stock
11500
21628
D
Stock Options (right to buy)
4.38
2020-12-15
4
M
0
7550
0.00
D
2022-06-04
Common Stock
7550
0
D
Stock Options (right to buy)
3.53
2020-12-15
4
M
0
4379
0.00
D
2023-01-28
Common Stock
4379
0
D
Stock Options (right to buy)
2.45
2020-12-15
4
M
0
6892
0.00
D
2024-01-03
Common Stock
6892
0
D
Represents shares swapped to cover the strike price of the options exercised.
All of the options were fully vested and exercisable as of the transaction date.
/s/ Christian Formica, Attorney-in-Fact
2020-12-17